Abstract
Drug resistance has become one of the biggest challenges in drug discovery and/or development and has attracted great research interests worldwide. During the past decade, computational strategies have been developed to predict target mutation-induced drug resistance. Meanwhile, various molecular design strategies, including targeting protein backbone, targeting highly conserved residues and dual/multiple targeting, have been used to design novel inhibitors for combating the drug resistance. In this article we review recent advances in development of computational methods for target mutation-induced drug resistance prediction and strategies for rational design of novel inhibitors that could be effective against the possible drug-resistant mutants of the target.
Original language | English |
---|---|
Pages (from-to) | 1121-1126 |
Number of pages | 6 |
Journal | Drug Discovery Today |
Volume | 17 |
Issue number | 19-20 |
DOIs | |
State | Published - Oct 2012 |
Bibliographical note
Funding Information:This work was supported in part by the National Basic Research Program of China (grant no. 2010CB126103 ), NSFC (grants nos. 20925206 and 20932005 ), NSF (grant CHE-1111761 ) and NIH (grant RC1MH088480 ).
Funding
This work was supported in part by the National Basic Research Program of China (grant no. 2010CB126103 ), NSFC (grants nos. 20925206 and 20932005 ), NSF (grant CHE-1111761 ) and NIH (grant RC1MH088480 ).
Funders | Funder number |
---|---|
National Science Foundation (NSF) | CHE-1111761 |
National Institutes of Health (NIH) | RC1MH088480 |
National Institute on Drug Abuse | R01DA025100 |
National Natural Science Foundation of China (NSFC) | 20925206, 20932005 |
National Basic Research Program of China (973 Program) | 2010CB126103 |
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery